Document is current
Any future updates will be listed below
-
Authors
Furneri, Gianluca http://orcid.org/0000-0002-4445-611X
Santoni, Laura
Ricella, Chiara
Prosperini, Luca
-
Funding
Funding for this research was provided by:
Biogen Italy
- License Information
-
More Information
Article History
Received: 29 December 2017
Accepted: 17 June 2019
First Online: 28 June 2019
Ethics approval and consent to participate
: The original data used in this study are from Prosperini et al., Mult Scler 2012 (available at: ExternalRef removed). Since this study was classified as post-marketing observation, Ethical Committee of Sapienza University, viale del policlinico 1, 00185, Rome, Italy, president prof Aldo Isidori provided exemption of approval and consent to conduct the study.
: Not applicable.
: Furneri G.: consulting fees from Biogen Italy for analysis conduction; Santoni L. and Ricella C.: employees of Biogen Italy; Prosperini L.: in the last 2 years, received consulting fees from Biogen and Novartis, and speaking honoraria and travel grants from Biogen, Genzyme, Novartis and Teva.
